BIG updates

The POSITIVE academic study was initiated to understand whether women, who desire to, can interrupt

As 2023 draws to a close, we extend our heartfelt gratitude to the European Health

In a significant step towards comprehending and addressing metastatic breast cancer, AURORA has just entered

Pink October and Breast Cancer Awareness Month have ended, underscoring global solidarity in the fight

The “Colours of India” Gala at Autoworld Brussels was a dazzling success, bringing together supporters

October 13th marks Metastatic Breast Cancer Awareness Day, a day dedicated to raising awareness about

On the occasion of the International Breast Cancer Awareness Month, the European Organisation for Research

Marathon Woman will run a marathon every day in 2024 and raise funds for BIG’s

On 26 April 2023, BIG signed an agreement with the European Health and Digital Executive

MISSING Act before they’re gone! Breast cancer research – saving lives The annual report is

ASCO 2023 Annual Meeting – 3 June 2023 We extend our warmest congratulations to Dr.

Around one in every eight women will develop breast cancer in their lifetime*. A percentage

4 June marks National Cancer Survivors Day (in the US) – a moment to recognise

The latest edition of BIG Research in Focus highlights the POSITIVE trial. Clic here to discover it.

The HERA study: a new standard of care for HER2-positive breast cancer The HERA study,

At this year’s St. Gallen Breast Cancer Congress (SGBCC, 15-18 March 2023), Professor Giuseppe Viale

Results of the final analysis of the NeoALTTO study have been published in the European